SCHEMBL21706873

SCHEMBL21706873

c1ccc(N(c2cccnc2)c2ccc3c(c2)c2c4ccccc4n(-c4ccccc4)c2n3-c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HDAC6 Q9UBN7 2/20 0.34
CYP3A4 P08684 3/20 0.33
CYP1A2 P05177 2/20 0.32
METAP2 P50579 1/20 0.32
ALOX12 P18054 1/20 0.32
KCNA5 P22460 1/20 0.32
HTT P42858 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PDE7A Q13946 1/20 0.31
POLB P06746 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TOP2A P11388 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
KMT2A Q03164 1/20 0.30
PRMT5 O14744 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21706874 0.93 KDM4E (0.36) KDM4EATML3MBTL1HDAC6CYP3A4
SCHEMBL21707149 0.92 ICMT (0.36) KDM4EATML3MBTL1HDAC6CYP3A4
SCHEMBL21707002 0.89 KDM4E (0.38) KDM4EATML3MBTL1HSD17B10
SCHEMBL21706872 0.88 MDM2 (0.34) KDM4EATML3MBTL1HDAC6CYP3A4
SCHEMBL21706857 0.84 KDM4E (0.40) KDM4EATML3MBTL1CYP3A4CYP1A2
SCHEMBL21706850 0.84 GFER (0.33) KDM4EATML3MBTL1HDAC6CYP3A4
SCHEMBL15730690 0.83 KDM4E (0.46) KDM4EATML3MBTL1CYP3A4CYP1A2
SCHEMBL21699390 0.83 KDM4E (0.41) KDM4EATML3MBTL1CYP3A4CYP1A2
SCHEMBL21707001 0.82 KDM4E (0.38) KDM4EATML3MBTL1HSD17B10POLB
SCHEMBL15730679 0.82 CYP1A2 (0.45) KDM4EATML3MBTL1CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200052223-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200052223-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 KDM4E 3395/4885ATM 969/4885L3MBTL1 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.